Dry Selection and Wet Evaluation of New 1,2-Disubstituted Nitroindazolin-3-One Derivatives as Promising Agents Against Trypanosoma cruzi
Abstract
1. Introduction
2. Results and Discussion
2.1. Development and Validation of the Computational Model
2.2. Screening and Experimental Evaluation of New Anti-Trypanosomal Compounds
2.3. Biological Activity
2.4. Chemistry
2.4.1. Electrochemical Characterization
2.4.2. Computational Analysis of Electronic Properties
2.5. Oxidative Stress and Spin Trapping Analysis by ESR
3. Materials and Methods
3.1. Computational Studies
3.1.1. Dataset and Design of Training and Prediction Sets
3.1.2. Molecular Descriptors
3.1.3. Classification Technique
3.1.4. Applicability Domain
3.1.5. Feature Importance Analysis
3.2. Experimental Assays
3.2.1. Chemical Assays
3.2.2. Biological Studies
3.3. Computational Details
4. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| Act | Activity |
| AD | applicability domain |
| AUC | Areas Under the Curve |
| BZN | benznidazole |
| CD | Chagas disease |
| CA | cluster analyses |
| CV | cyclic voltammetry |
| DNDi | Drugs for Neglected Diseases initiative |
| EPR | electron paramagnetic resonance |
| ESR | Electron Spin Resonance |
| HMDE | hanging mercury drop electrode |
| HOMO | highest occupied molecular orbital |
| IC50 | half-maximal inhibitory concentration |
| k-NNCA | k nearest-neighbor cluster analysis |
| k-MCA | k-means cluster analysis |
| LUMO | lowest unoccupied molecular orbital |
| NFX | nifurtimox |
| PS | prediction set |
| QSARs | quantitative structure–activity relationships |
| RF | Random Forest |
| ROS | reactive oxygen species |
| ROC | Receiver Operating Characteristic |
| SHAP | Shapley Additive Explanations |
| SD | standard deviation |
| TS | training set |
| TcNTRs | T. cruzi nitroreductases |
References
- de Sousa, A.S.; Vermeij, D.; Ramos, A.N.; Luquetti, A.O. Chagas disease. Lancet 2024, 403, 203–218. [Google Scholar] [CrossRef] [Scilit]
- Kropf, S.P.; Lima, N.T. The history of Chagas disease: Reflections on science in action. Mem. Inst. Oswaldo Cruz 2022, 117, e200372. [Google Scholar] [CrossRef] [Scilit]
- Beltran-Hortelano, I.; Alcolea, V.; Font, M.; Pérez-Silanes, S. Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease. Bioorg. Med. Chem. 2022, 58, 116577. [Google Scholar] [CrossRef] [Scilit]
- Centers for Disease Control and Prevention. Chagas Disease: About Chagas Disease. Available online: https://www.cdc.gov/chagas/about/index.html (accessed on 14 April 2025).
- WHO. World Chagas Disease Day 2025. Available online: https://www.who.int/campaigns/world-chagas-disease-day/2025 (accessed on 14 April 2025).
- Echeverria, L.E.; Morillo, C.A. American Trypanosomiasis (Chagas Disease). Infect. Dis. Clin. N. Am. 2019, 33, 119–134. [Google Scholar] [CrossRef] [Scilit]
- Bern, C. Chagas’ Disease. N. Engl. J. Med. 2015, 373, 456–466. [Google Scholar] [CrossRef] [Scilit]
- Mills, R.M. Chagas Disease: Epidemiology and Barriers to Treatment. Am. J. Med. 2020, 133, 1262–1265. [Google Scholar] [CrossRef] [Scilit]
- Pérez-Molina, J.A.; Molina, I. Chagas disease. Lancet 2018, 391, 82–94. [Google Scholar] [CrossRef] [Scilit]
- Organización Mundial de la Salud. Chagas Disease (American Trypanosomiasis). Available online: https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis) (accessed on 21 April 2025).
- Sosa-Estani, S.; Segura, E.L. Integrated control of Chagas disease for its elimination as public health problem—A Review. Mem. Inst. Oswaldo Cruz 2015, 110, 289–298. [Google Scholar] [CrossRef] [Scilit]
- Prieto, J.; Talevi, A.; Bruno-Blanch, L. Application of linear discriminant analysis in the virtual screening of antichagasic drugs through trypanothione reductase inhibition. Mol. Div. 2006, 10, 361–375. [Google Scholar] [CrossRef] [Scilit]
- Castillo-Garit, J.A.; del Toro-Cortés, O.; Vega, M.C.; Rolón, M.; Rojas de Arias, A.; Casañola-Martin, G.M.; Escario, J.A.; Gómez-Barrio, A.; Marrero-Ponce, Y.; Torrens, F.; et al. Bond-based bilinear indices for computational discovery of novel trypanosomicidal drug-like compounds through virtual screening. Eur. J. Med. Chem. 2015, 96, 238–244. [Google Scholar] [CrossRef] [Scilit]
- Scarim, C.B.; Jornada, D.H.; Chelucci, R.C.; de Almeida, L.; dos Santos, J.L.; Chung, M.C. Current advances in drug discovery for Chagas disease. Eur. J. Med. Chem. 2018, 155, 824–838. [Google Scholar] [CrossRef] [Scilit]
- Urbina, J.A. Specific chemotherapy of Chagas disease: Relevance, current limitations and new approaches. Acta Trop. 2010, 115, 55–68. [Google Scholar] [CrossRef] [Scilit]
- Planche, A.S.; Scotti, M.T.; Emerenciano, V.d.P.; López, A.G.; Pérez, E.M.; Uriarte, E. Designing novel antitrypanosomal agents from a mixed graph-theoretical substructural approach. J. Comput. Chem. 2010, 31, 882–894. [Google Scholar] [CrossRef] [Scilit]
- Castillo-Garit, J.A.; Del Toro-Cortés, O.; Kouznetsov, V.V.; Puentes, C.O.; Romero Bohórquez, A.R.; Vega, M.C.; Rolón, M.; Escario, J.A.; Gómez-Barrio, A.; Marrero-Ponce, Y.; et al. Identification In Silico and In Vitro of Novel Trypanosomicidal Drug-Like Compounds. Chem. Biol. Drug Des. 2012, 80, 38–45. [Google Scholar] [CrossRef] [Scilit]
- Moncada-Basualto, M.; Saavedra-Olavarría, J.; Rivero-Jerez, P.S.; Rojas, C.; Maya, J.D.; Liempi, A.; Zúñiga-Bustos, M.; Olea-Azar, C.; Lapier, M.; Pérez, E.G.; et al. Assessment of the Activity of Nitroisoxazole Derivatives against Trypanosoma cruzi. Molecules 2024, 29, 2762. [Google Scholar] [CrossRef] [Scilit]
- Pozo-Martínez, J.; Arán, V.J.; Zúñiga-Bustos, M.; Parra-Magna, S.; Rocha-Valderrama, E.; Liempi, A.; Castillo, C.; Olea-Azar, C.; Moncada-Basualto, M. In Vitro Evaluation of New 5-Nitroindazolin-3-one Derivatives as Promising Agents against Trypanosoma cruzi. Int. J. Mol. Sci. 2024, 25, 11107. [Google Scholar] [CrossRef] [Scilit]
- Fonseca-Berzal, C.; Ibáñez-Escribano, A.; de Castro, S.; Escario, J.A.; Gómez-Barrio, A.; Arán, V.J. 5-Nitroindazole-based compounds: Further studies for activity optimization as anti-Trypanosoma cruzi agents. Acta Trop. 2022, 234, 106607. [Google Scholar] [CrossRef] [Scilit]
- Padilla, A.M.; Wang, W.; Akama, T.; Carter, D.S.; Easom, E.; Freund, Y.; Halladay, J.S.; Liu, Y.; Hamer, S.A.; Hodo, C.L.; et al. Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primates. Nat. Microbiol. 2022, 7, 1536–1546. [Google Scholar] [CrossRef] [Scilit]
- Castillo-Garit, J.A.; Vega, M.C.; Rolón, M.; Marrero-Ponce, Y.; Gómez-Barrio, A.; Escario, J.A.; Bello, A.A.; Montero, A.; Torrens, F.; Pérez-Giménez, F.; et al. Ligand-based discovery of novel trypanosomicidal drug-like compounds: In silico identification and experimental support. Eur. J. Med. Chem. 2011, 46, 3324–3330. [Google Scholar] [CrossRef] [Scilit]
- Castillo-Garit, J.A.; Vega, M.C.; Rolon, M.; Marrero-Ponce, Y.; Kouznetsov, V.; Torres, D.F.; Gómez-Barrio, A.; Alvarez, A.; Montero, A.; Torrens, F.; et al. Computational discovery of novel trypanosomicidal drug-like chemicals by using bond-based non-stochastic and stochastic quadratic maps and linear discriminant analysis. Eur. J. Pharm. Sci. 2010, 39, 30–36. [Google Scholar] [CrossRef] [Scilit]
- Castillo-Garit, J.A.; Barigye, S.J.; Pham-the, H.; Pérez-Doñate, V.; Torrens, F.; Pérez-Giménez, F. Computational identification of chemical compounds with potential anti-Chagas activity using a classification tree. SAR. QSAR Environ. Res. 2021, 32, 71–83. [Google Scholar] [CrossRef] [Scilit]
- Marrero-Ponce, Y.; Martínez-Albelo, E.; Casañola-Martín, G.; Castillo-Garit, J.; Echevería-Díaz, Y.; Zaldivar, V.; Tygat, J.; Borges, J.; García-Domenech, R.; Torrens, F.; et al. Bond-based linear indices of the non-stochastic and stochastic edge-adjacency matrix. 1. Theory and modeling of ChemPhys properties of organic molecules. Mol. Divers. 2010, 14, 731–753. [Google Scholar] [CrossRef] [Scilit]
- Cañizares-Carmenate, Y.; Mena-Ulecia, K.; Perera-Sardiña, Y.; Torrens, F.; Castillo-Garit, J.A. An approach to identify new antihypertensive agents using Thermolysin as model: In silico study based on QSARINS and docking. Arab. J. Chem. 2019, 12, 4861–4877. [Google Scholar] [CrossRef] [Scilit]
- Barigye, S.J.; Freitas, M.P.; Ausina, P.; Zancan, P.; Sola-Penna, M.; Castillo-Garit, J.A. Discrete Fourier Transform-Based Multivariate Image Analysis: Application to Modeling of Aromatase Inhibitory Activity. ACS Comb. Sci. 2018, 20, 75–81. [Google Scholar] [CrossRef] [Scilit]
- Castillo-Garit, J.A.; Marrero-Ponce, Y.; Torrens, F.; García-Domenech, R.; Rodríguez-Borges, J.E. Applications of Bond-Based 3D-Chiral Quadratic Indices in QSAR Studies Related to Central Chirality Codification. QSAR Comb. Sci. 2009, 28, 1465–1477. [Google Scholar] [CrossRef] [Scilit]
- Castillo-Garit, J.A.; Marrero-Ponce, Y.; Barigye, S.J.; Medina-Marrero, R.; Bernal, M.G.; Vega, J.M.G.d.l.; Torrens, F.; Arán, V.J.; Pérez-Giménez, F.; García-Domenech, R.; et al. In silico Antibacterial Activity Modeling Based on the TOMOCOMD-CARDD Approach. J. Braz. Chem. Soc. 2015, 26, 1218–1226. [Google Scholar] [CrossRef] [Scilit]
- Juan, A.C.-G.; Yudith, C.-C.; Hai, P.-T.; Virginia, P.-D.; Francisco, T.; Facundo, P.-G. A Review of Computational Approaches Targeting SARS-CoV-2 Main Protease to the Discovery of New Potential Antiviral Compounds. Curr. Top. Med. Chem. 2023, 23, 3–16. [Google Scholar] [CrossRef] [Scilit]
- Barigye, S.J.; García de la Vega, J.M.; Perez-Castillo, Y.; Castillo-Garit, J.A. Evolutionary Algorithm-Based Generation of Optimum Peptide Sequences with Dengue Virus Inhibitory Activity. Fut. Med. Chem. 2021, 13, 993–1000. [Google Scholar] [CrossRef] [Scilit]
- Castillo-Garit, J.A.; Soria-Merino, M.; Mena-Ulecia, K.; Romero-Otero, M.; Pérez-Doñate, V.; Torrens, F.; Pérez-Giménez, F. Combining QSAR and Molecular Docking for the Methodological Design of Novel Radiotracers Targeting Parkinson’s Disease. Appl. Sci. 2025, 15, 8134. [Google Scholar] [CrossRef] [Scilit]
- Vega, M.C.; Rolón, M.; Montero-Torres, A.; Fonseca-Berzal, C.; Escario, J.A.; Gómez-Barrio, A.; Gálvez, J.; Marrero-Ponce, Y.; Arán, V.J. Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug. Eur. J. Med. Chem. 2012, 58, 214–227. [Google Scholar] [CrossRef] [Scilit][Green Version]
- Fonseca-Berzal, C.; França da Silva, C.; Bernardino da Silva, P.; Meuser Batista, M.; Gómez-Barrio, A.; Vela, N.; Arán, V.J.; Correia Soeiro, M.d.N. Nitroindazolinone derivatives: Assessing the impact of the nitro group location on the activity against Trypanosoma cruzi. Parasitology 2026, 1–15. [Google Scholar] [CrossRef] [Scilit]
- Rodríguez, J.; Arán, V.J.; Boiani, L.; Olea-Azar, C.; Lavaggi, M.L.; González, M.; Cerecetto, H.; Maya, J.D.; Carrasco-Pozo, C.; Cosoy, H.S. New potent 5-nitroindazole derivatives as inhibitors of Trypanosoma cruzi growth: Synthesis, biological evaluation, and mechanism of action studies. Bioorganic Med. Chem. 2009, 17, 8186–8196. [Google Scholar] [CrossRef] [Scilit]
- Fonseca-Berzal, C.; Escario, J.A.; Arán, V.J.; Gómez-Barrio, A. Further insights into biological evaluation of new anti-Trypanosoma cruzi 5-nitroindazoles. Parasitol. Res. 2014, 113, 1049–1056. [Google Scholar] [CrossRef] [Scilit]
- Fonseca-Berzal, C.; Da Silva, P.B.; Da Silva, C.F.; Vasconcelos, M.; Batista, M.M.; Escario, J.A.; ArÁN, V.J.; GÓMez-Barrio, A.; Soeiro, M.D.E.N.C. Exploring the potential activity spectrum of two 5-nitroindazolinone prototypes on different Trypanosoma cruzi strains. Parasitol. Open 2015, 1, e1. [Google Scholar] [CrossRef] [Scilit][Green Version]
- Fonseca-Berzal, C.; Silva, C.F.d.; Batista, M.M.; Guedes-da-Silva, F.H.; Vasconcelos, M.; Demarque, K.C.; Escario, J.A.; Arán, V.J.; Soeiro, M.d.N.C.; Gómez-Barrio, A. Activity of 2-benzyl-1-(2-hydroxyethyl)-5-nitroindazolin-3-one on Trypanosoma cruzi Bloodstream Trypomastigotes (Y strain): In Vitro and In Vivo Studies. Proceedings 2017, 1, 655. [Google Scholar] [CrossRef] [Scilit]
- Fonseca-Berzal, C.; da Silva, C.F.; Batista, D.d.G.J.; de Oliveira, G.M.; Cumella, J.; Batista, M.M.; Peres, R.B.; Silva da Gama Nefertiti, A.; Escario, J.A.; Gómez-Barrio, A.; et al. Activity profile of two 5-nitroindazole derivatives over the moderately drug-resistant Trypanosoma cruzi Y strain (DTU TcII): In vitro and in vivo studies. Parasitology 2020, 147, 1216–1228. [Google Scholar] [CrossRef] [Scilit]
- Fonseca-Berzal, C.; Ibáñez-Escribano, A.; Reviriego, F.; Cumella, J.; Morales, P.; Jagerovic, N.; Nogal-Ruiz, J.J.; Escario, J.A.; da Silva, P.B.; Soeiro, M.d.N.C.; et al. Antichagasic and trichomonacidal activity of 1-substituted 2-benzyl-5-nitroindazolin-3-ones and 3-alkoxy-2-benzyl-5-nitro-2H-indazoles. Eur. J. Med. Chem. 2016, 115, 295–310. [Google Scholar] [CrossRef] [Scilit]
- Fonseca-Berzal, C.; Ibáñez-Escribano, A.; Vela, N.; Cumella, J.; Nogal-Ruiz, J.J.; Escario, J.A.; da Silva, P.B.; Batista, M.M.; Soeiro, M.d.N.C.; Sifontes-Rodríguez, S.; et al. Antichagasic, Leishmanicidal, and Trichomonacidal Activity of 2-Benzyl-5-nitroindazole-Derived Amines. ChemMedChem 2018, 13, 1246–1259. [Google Scholar] [CrossRef] [Scilit]
- Maria Aravena, C.; Claudio Olea, A.; Cerecetto, H.; González, M.; Maya, J.D.; Rodríguez-Becerra, J. Potent 5-nitrofuran derivatives inhibitors of Trypanosoma cruzi growth: Electrochemical, spectroscopic and biological studies. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2011, 79, 312–319. [Google Scholar] [CrossRef] [Scilit]
- Boiani, L.; Gerpe, A.; Arán, V.J.; Torres de Ortiz, S.; Serna, E.; Vera de Bilbao, N.; Sanabria, L.; Yaluff, G.; Nakayama, H.; Rojas de Arias, A.; et al. In vitro and in vivo antitrypanosomatid activity of 5-nitroindazoles. Eur. J. Med. Chem. 2009, 44, 1034–1040. [Google Scholar] [CrossRef] [Scilit]
- Xavier, J.A.; Silva, T.L.; Torres-Santos, E.C.; de Vasconcelos, C.C.; Boane, A.; dos Santos, R.A.; Xavier, A.F.A.; Goulart, M.O.F. Unveiling the relevance of the redox character of nitroaromatic and nitroheteroaromatic compounds as potential medicines. Curr. Opin. Electrochem. 2021, 29, 100740. [Google Scholar] [CrossRef] [Scilit]
- Cirqueira, M.L.; Bortot, L.O.; Bolean, M.; Aleixo, M.A.A.; Luccas, P.H.; Costa-Filho, A.J.; Ramos, A.P.; Ciancaglini, P.; Nonato, M.C. Trypanosoma cruzi nitroreductase: Structural features and interaction with biological membranes. Int. J. Biol. Macromol. 2022, 221, 891–899. [Google Scholar] [CrossRef] [Scilit]
- Aguilera-Venegas, B.; Olea-Azar, C.; Arán, V.J.; Speisky, H. Indazoles: A New Top Seed Structure in the Search of Efficient Drugs Against Trypanosoma Cruzi. Future Med. Chem. 2013, 5, 1843–1859. [Google Scholar] [CrossRef] [Scilit]
- STATISTICA (Data Analysis Software System), version 6; StatSoft, Inc.: Tulsa, OK, USA, 2001.
- Alvascience. alvaDesc (Software for Molecular Descriptors Calculation), version 3.0.6; Alvascience: Vitacura, Chile, 2025.
- Ziegler, A.; König, I.R. Mining data with random forests: Current options for real-world applications. WIREs Data Min. Knowl. Discov. 2014, 4, 55–63. [Google Scholar] [CrossRef] [Scilit]
- Genuer, R.; Poggi, J.-M.; Tuleau-Malot, C. Variable selection using random forests. Pattern Recognit. Lett. 2010, 31, 2225–2236. [Google Scholar] [CrossRef] [Scilit]
- Tripoliti, E.E.; Fotiadis, D.I.; Manis, G. Modifications of the construction and voting mechanisms of the Random Forests Algorithm. Data Knowl. Eng. 2013, 87, 41–65. [Google Scholar] [CrossRef] [Scilit]
- Pedregosa, F.; Varoquaux, G.; Gramfort, A.; Michel, V.; Thirion, B.; Grisel, O.; Blondel, M.; Müller, A.; Nothman, J.; Louppe, G.; et al. Scikit-learn: Machine Learning in Python. J. Mach. Learn. Res. 2011, 12, 2825–2830. [Google Scholar]
- Netzeva, T.I.; Aptula, A.O.; Benfenati, E.; Cronin, M.T.; Gini, G.; Lessigiarska, I.; Maran, U.; Vracko, M.; Schuurmann, G. Description of the electronic structure of organic chemicals using semiempirical and ab initio methods for development of toxicological QSARs. J. Chem. Inf. Model. 2005, 45, 106–114. [Google Scholar] [CrossRef] [Scilit]
- Castillo-Garit, J.A.; Abad, C.; Casañola-Martin, G.M.; Barigye, S.J.; Torrens, F.; Torreblanca, A. Prediction of Aquatic Toxicity of Benzene Derivatives to Tetrahymena pyriformis According to OECD Principles. Curr. Pharm. Des. 2016, 22, 5085–5094. [Google Scholar] [CrossRef] [Scilit]
- Gramatica, P. Principles of QSAR Models Validation: Internal and External QSAR. QSAR Comb. Sci. 2007, 26, 694–701. [Google Scholar] [CrossRef] [Scilit]
- Eriksson, L.; Jaworska, J.; Worth, A.P.; Cronin, M.T.; McDowell, R.M.; Gramatica, P. Methods for Reliability and Uncertainty Assessment and for Applicability Evaluations of Classification- and Regression-Based QSARs. Environ. Health Perspect. 2003, 111, 1361–1375. [Google Scholar] [CrossRef] [Scilit]
- Rodríguez-Pérez, R.; Bajorath, J. Interpretation of Compound Activity Predictions from Complex Machine Learning Models Using Local Approximations and Shapley Values. J. Med. Chem. 2020, 63, 8761–8777. [Google Scholar] [CrossRef] [Scilit]
- Rodríguez-Pérez, R.; Bajorath, J. Interpretation of machine learning models using shapley values: Application to compound potency and multi-target activity predictions. J. Comput.-Aided Mol. Des. 2020, 34, 1013–1026. [Google Scholar] [CrossRef] [Scilit]
- Pfannstiel, K.; Janecke, J. Darstellung von o-Hydrazino-benzoesäuren und Indazolonen durch Reduktion diazotierter Anthranilsäuren mit Schwefliger Säure. Berichte Dtsch. Chem. Ges. 1942, 75, 1096–1107. [Google Scholar] [CrossRef] [Scilit]
- Boulton, A.J.; Fletcher, I.J.; Katritzky, A.R. Heterocyclic rearrangements. Part XIII. The conversion of a nitro-2,1-benzisoxazole into an acylbenzofurazan, and some unsuccessful rearrangements and oxygen transfer reactions. J. Chem. Soc. C. 1971, 6, 1193–1196. [Google Scholar] [CrossRef] [Scilit]
- Reyes, C.; González, C.R.; Alvarado, S.; Flores, L.; Martin, C.; Oyarce, A.; Aylwin, M.P.; Canals, M.; Parra, A.; Valderrama, L. Chagas disease in northern Chile: Detection of Trypanosoma cruzi in children, dogs and triatomine bugs. Acta Trop. 2022, 235, 106631. [Google Scholar] [CrossRef] [Scilit]
- Pozo-Martínez, J.; Salgado, F.; Liempi, A.; Kemmerling, U.; Mera-Adasme, R.; Olea-Azar, C.; Moncada-Basualto, M.; Borges, F.; Uriarte, E.; Matos, M.J. Synthesis and study of the trypanocidal activity of catechol-containing 3-arylcoumarins, inclusion in β-cyclodextrin complexes and combination with benznidazole. Arab. J. Chem. 2022, 15, 103641. [Google Scholar] [CrossRef] [Scilit]
- Rodríguez-Corrales, J.Á.; Josan, J.S. Resazurin Live Cell Assay: Setup and Fine-Tuning for Reliable Cytotoxicity Results. In Proteomics for Drug Discovery: Methods and Protocols; Lazar, I.M., Kontoyianni, M., Lazar, A.C., Eds.; Springer: New York, NY, USA, 2017; pp. 207–219. [Google Scholar]
- Sadeghi, M.; Sarvi, S.; Emami, S.; Khalilian, A.; Hosseini, S.A.; Montazeri, M.; Shahdin, S.; Nayeri, T.; Daryani, A. Evaluation of anti-parasitic activities of new quinolones containing nitrofuran moiety against Toxoplasma gondii. Exp. Parasitol. 2022, 240, 108344. [Google Scholar] [CrossRef] [Scilit]
- Rolón, M.; Vega, C.; Escario, J.A.; Gómez-Barrio, A. Development of resazurin microtiter assay for drug sensibility testing of Trypanosoma cruzi epimastigotes. Parasitol. Res. 2006, 99, 103–107. [Google Scholar] [CrossRef] [Scilit]
- Rostán, S.; Pozo-Martínez, J.; Arcos, M.A.; Moncada-Basualto, M.; Aguilera, E.; Alvarez, N.; Olea-Azar, C.; Mahler, G.; Otero, L. Pt(II) and Pd(II) complexes with coumarin-thiosemicarbazone hybrid ligands and triphenylphosphine coligand as potential anti T. cruzi agents. J. Mol. Struct. 2024, 1313, 138711. [Google Scholar] [CrossRef] [Scilit]
- Neese, F. The ORCA program system. Wiley Interdiscip. Rev. Comput. 2012, 2, 73–78. [Google Scholar] [CrossRef] [Scilit]
- Polo-Cuadrado, E.; Osorio, E.; Acosta-Quiroga, K.; Camargo-Ayala, P.A.; Brito, I.; Rodriguez, J.; Alderete, J.B.; Forero-Doria, O.; Blanco-Acuña, E.F.; Gutiérrez, M. Nonlinear optical and spectroscopic properties, thermal analysis, and hemolytic capacity evaluation of quinoline-1,3-benzodioxole chalcone. RSC Adv. 2024, 14, 10199–10208. [Google Scholar] [CrossRef] [Scilit]
- Acosta-Quiroga, K.; Polo-Cuadrado, E.; Percino, M.J.; Blanco-Acuña, E.; Villaman, D.; Pérez-Gutiérrez, E.; Patiño, M.E.; Alderete, J.B.; Gonzalez, R.; Saavedra-Olavarría, J.; et al. Optoelectronic and NLO potential of styryl-functionalized nitroisoxazoles for OLED technologies. J. Mater. Chem. C. 2025, 13, 9083–9098. [Google Scholar] [CrossRef] [Scilit]
- Polo-Cuadrado, E.; Acosta-Quiroga, K.; Rojas-Peña, C.; Rodriguez-Nuñez, Y.A.; Blanco-Acuña, E.F.; Lopez, J.J.; Brito, I.; Cisterna, J.; Alderete, J.B.; Gutiérrez, M. Regioselective cyclocondensations with thiobarbituric acid: Spirocyclic and azocine products, X-ray characterization, and antioxidant evaluation. RSC Adv. 2025, 15, 8609–8621. [Google Scholar] [CrossRef] [Scilit]
- Acosta-Quiroga, K.; Rocha-Valderrama, E.; Zúñiga-Bustos, M.; Mera-Adasme, R.; Cabrera-Barjas, G.; Olea-Azar, C.; Moncada-Basualto, M. Gross Antioxidant Capacity and Anti-Inflammatory Potential of Flavonol Oxidation Products: A Combined Experimental and Theoretical Study. Antioxidants 2025, 14, 479. [Google Scholar] [CrossRef] [Scilit]
- Fuentealba, P.; Florez, E.; Tiznado, W. Topological Analysis of the Fukui Function. J. Chem. Theory Comput. 2010, 6, 1470–1478. [Google Scholar] [CrossRef] [Scilit]
- Osorio, E.; Pérez, E.G.; Areche, C.; Ruiz, L.M.; Cassels, B.K.; Flórez, E.; Tiznado, W. Why is quercetin a better antioxidant than taxifolin? Theoretical study of mechanisms involving activated forms. J. Mol. Mod. 2013, 19, 2165–2172. [Google Scholar] [CrossRef] [Scilit]
- Lu, T.; Chen, F. Multiwfn: A multifunctional wavefunction analyzer. J. Comput. Chem. 2012, 33, 580–592. [Google Scholar] [CrossRef] [Scilit]













| H-049, VE2sign_B(m), SsssCH, SpMin3_Bh(i), s3_numAroBonds, X1A | ||||
|---|---|---|---|---|
| Accuracy | Sensibility | Specificity | fpr 1 | |
| Training set | 0.821 | 0.798 | 0.849 | 0.151 |
| Test set | 0.787 | 0.734 | 0.855 | 0.145 |
| Compounds | Pred. | IC50/µM | SI * | ||
|---|---|---|---|---|---|
| Trypomastigote of T. cruzi Dm28c | VERO Cells | EA.hy926 Cells | |||
| 1a | I | 189.7 ± 1.4 | >300 | >300 | >1.58 |
| 2a | I | 149.6 ± 2.0 | >300 | >300 | >2.00 |
| 1b | I | 164.4 ± 1.3 | >300 | >300 | >1.82 |
| 2b | I | 170.6 ± 1.1 | >300 | >300 | >1.76 |
| 1c | I | 71.3 ± 0.9 | >300 | >300 | >4.21 |
| 2c | A | 40.9 ± 0.8 | >300 | >300 | >7.33 |
| 1d | I | 212.4 ± 1.3 | >300 | >300 | >1.41 |
| 2d | I | 142.1 ± 2.1 | >300 | >300 | >2.11 |
| NFX | 21.5 ± 1.4 | >300 | >300 | >13.95 | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Castillo-Garit, J.A.; Pozo-Martinez, J.; Rocha-Valderrama, E.; Rojas-Peña, C.; Acosta-Quiroga, K.; Arán, V.J.; Olea-Azar, C.; Casañola-Martin, G.M.; Rasulev, B.; Torrens, F.; et al. Dry Selection and Wet Evaluation of New 1,2-Disubstituted Nitroindazolin-3-One Derivatives as Promising Agents Against Trypanosoma cruzi. Pharmaceuticals 2026, 19, 1473. https://doi.org/10.3390/ph19091473
Castillo-Garit JA, Pozo-Martinez J, Rocha-Valderrama E, Rojas-Peña C, Acosta-Quiroga K, Arán VJ, Olea-Azar C, Casañola-Martin GM, Rasulev B, Torrens F, et al. Dry Selection and Wet Evaluation of New 1,2-Disubstituted Nitroindazolin-3-One Derivatives as Promising Agents Against Trypanosoma cruzi. Pharmaceuticals. 2026; 19(9):1473. https://doi.org/10.3390/ph19091473
Chicago/Turabian StyleCastillo-Garit, Juan A., Josue Pozo-Martinez, Esteban Rocha-Valderrama, Cristian Rojas-Peña, Karen Acosta-Quiroga, Vicente J. Arán, Claudio Olea-Azar, Gerardo M. Casañola-Martin, Bakhtiyor Rasulev, Francisco Torrens, and et al. 2026. "Dry Selection and Wet Evaluation of New 1,2-Disubstituted Nitroindazolin-3-One Derivatives as Promising Agents Against Trypanosoma cruzi" Pharmaceuticals 19, no. 9: 1473. https://doi.org/10.3390/ph19091473
APA StyleCastillo-Garit, J. A., Pozo-Martinez, J., Rocha-Valderrama, E., Rojas-Peña, C., Acosta-Quiroga, K., Arán, V. J., Olea-Azar, C., Casañola-Martin, G. M., Rasulev, B., Torrens, F., Pérez-Giménez, F., & Moncada-Basualto, M. (2026). Dry Selection and Wet Evaluation of New 1,2-Disubstituted Nitroindazolin-3-One Derivatives as Promising Agents Against Trypanosoma cruzi. Pharmaceuticals, 19(9), 1473. https://doi.org/10.3390/ph19091473

